Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis.

BackgroundThe plaque reduction neutralization test (PRNT) remains the gold standard for the detection of serologic immune responses to dengue virus (DENV). While the basic concept of the PRNT remains constant, this test has evolved in multiple laboratories, introducing variation in materials and methods. Despite the importance of laboratory-to-laboratory comparability in DENV vaccine development, the effects of differing PRNT techniques on assay results, particularly the use of different dengue strains within a serotype, have not been fully characterized.MethodsWe conducted a systematic review and pooled analysis of published literature reporting individual-level PRNT titers to identify factors associated with heterogeneity in PRNT results and compared variation between strains within DENV serotypes and between articles using hierarchical models.ResultsThe literature search and selection criteria identified 8 vaccine trials and 25 natural exposure studies reporting 4,411 titers from 605 individuals using 4 different neutralization percentages, 3 cell lines, 12 virus concentrations and 51 strains. Of 1,057 titers from primary DENV exposure, titers to the exposure serotype were consistently higher than titers to non-exposure serotypes. In contrast, titers from secondary DENV exposures (n = 628) demonstrated high titers to exposure and non-exposure serotypes. Additionally, PRNT titers from different strains within a serotype varied substantially. A pooled analysis of 1,689 titers demonstrated strain choice accounted for 8.04% (90% credible interval [CrI]: 3.05%, 15.7%) of between-titer variation after adjusting for secondary exposure, time since DENV exposure, vaccination and neutralization percentage. Differences between articles (a proxy for inter-laboratory differences) accounted for 50.7% (90% CrI: 30.8%, 71.6%) of between-titer variance.ConclusionsAs promising vaccine candidates arise, the lack of standardized assays among diagnostic and research laboratories make unbiased inferences about vaccine-induced protection difficult. Clearly defined, widely accessible reference reagents, proficiency testing or algorithms to adjust for protocol differences would be a useful first step in improving dengue PRNT comparability and quality assurance

Enhanced thermionic-dominated photoresponse in graphene Schottky junctions

Vertical heterostructures of van der Waals materials enable new pathways to tune charge and energy transport characteristics in nanoscale systems. We propose that graphene Schottky junctions can host a special kind of photoresponse which is characterized by strongly coupled heat and charge flows that run vertically out of the graphene plane. This regime can be accessed when vertical energy transport mediated by thermionic emission of hot carriers overwhelms electron-lattice cooling as well as lateral diffusive energy transport. As such, the power pumped into the system is efficiently extracted across the entire graphene active area via thermionic emission of hot carriers into a semiconductor material. Experimental signatures of this regime include a large and tunable internal responsivity ${\cal R}$ with a non-monotonic temperature dependence. In particular, ${\cal R}$ peaks at electronic temperatures on the order of the Schottky potential $\phi$ and has a large upper limit ${\cal R} \le e/\phi$ ($e/\phi=10\,{\rm A/W}$ when $\phi = 100\,{\rm meV}$). Our proposal opens up new approaches for engineering the photoresponse in optically-active graphene heterostructures.Comment: 6 pages, 2 figure

Event-Related Potentials of Individuals with Attention-Deficit/Hyperactivity Disorder Performing the Attention Network Task

The current study sought to investigate the neural basis of attention-deficit/hyperactivity disorder (ADHD) by examining the performance of individuals with ADHD on the Attentional Networks Test (ANT) by Fan, McCandliss, Sommer, Raz, and Posner (2002), while recording electroencephalography (EEG) utilizing event-related potentials (ERP) methodology. Fifty-seven university students were divided into three groups: control, ADHD-inattentive subtype (ADHD-IA), and ADHD-combined/hyperactive impulsive subtype (ADHD-C/HI). The average peak amplitudes of the P300 waveform for each group were compared and analyzed for performance on each attention network measured by the ANT: the alerting network, the orienting network, and the executive control network. The average P3 peaks were significantly different for controls in comparison to the ADHD-IA group for the alerting and executive networks, and for controls in comparison to ADHD-C/HI for the orienting network. Controls and ADHD-IA had faster behavioral reaction times (RTs) than ADHD-C/HI, but all groups performed at a high level of accuracy. Results suggest that ADHD-IA and ADHD-C/HI comprise heterogeneous disorders. Not only do their symptoms differ but also their electrical potentials compared to controls

Kato square root problem with unbounded leading coefficients

We prove the Kato conjecture for elliptic operators, $L=-\nabla\cdot\left((\mathbf A+\mathbf D)\nabla\ \right)$, with $\mathbf A$ a complex measurable bounded coercive matrix and $\mathbf D$ a measurable real-valued skew-symmetric matrix in $\mathbb{R}^n$ with entries in $BMO(\mathbb{R}^n)$;\, i.e., the domain of $\sqrt{L}\,$ is the Sobolev space $\dot H^1(\mathbb{R}^n)$ in any dimension, with the estimate $\|\sqrt{L}\, f\|_2\lesssim \| \nabla f\|_2$

Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces

The diverse composition and structure of extracellular matrix (ECM) interfaces encountered by tumor cells at secondary tissue sites can influence metastatic progression. Extensive in vitro and in vivo data has confirmed that metastasizing tumor cells can adopt different migratory modes in response to their microenvironment. Here we present a model that uses human stromal cell-derived matrices to demonstrate that plasticity in tumor cell movement is controlled by the tumor-associated collagen receptor Endo180 (CD280, CLEC13E, KIAA0709, MRC2, TEM9, uPARAP) and the crosslinking of collagen fibers by stromal-derived lysyl oxidase (LOX). Human osteoblast-derived and fibroblast-derived ECM supported a rounded ‘amoeboid-like’ mode of cell migration and enhanced Endo180 expression in three prostate cancer cell lines (PC3, VCaP, DU145). Genetic silencing of Endo180 reverted PC3 cells from their rounded mode of migration towards a bipolar ‘mesenchymal-like’ mode of migration and blocked their translocation on human fibroblast-derived and osteoblast-derived matrices. The concomitant decrease in PC3 cell migration and increase in Endo180 expression induced by stromal LOX inhibition indicates that the Endo180-dependent rounded mode of prostate cancer cell migration requires ECM crosslinking. In conclusion, this study introduces a realistic in vitro model for the study of metastatic prostate cancer cell plasticity and pinpoints the cooperation between tumor-associated Endo180 and the stiff microenvironment imposed by stromal-derived LOX as a potential target for limiting metastatic progression in prostate cancer

Survival outcome and EMT suppression mediated by a lectin domain interaction of Endo180 and CD147

Epithelial cell-cell contacts maintain normal glandular tissue homeostasis, and their breakage can trigger epithelial-to-mesenchymal transition (EMT), a fundamental step in the development of metastatic cancer. Despite the ability of C-type lectin domains (CTLD) to modulate cell-cell adhesion, it is not known if they modulate epithelial adhesion in EMT and tumor progression. Here, the multi-CTLD mannose receptor, Endo180 (MRC2/uPARAP), was shown using the Kaplan-Meier analysis to be predictive of survival outcome in men with early prostate cancer. A proteomic screen of novel interaction partners with the fourth CTLD (CTLD4) in Endo180 revealed that its complex with CD147 is indispensable for the stability of three-dimensional acini formed by nontransformed prostate epithelial cells (PEC). Mechanistic study using knockdown of Endo180 or CD147, and treatment with an Endo180 mAb targeting CTLD4 (clone 39.10), or a dominant-negative GST-CTLD4 chimeric protein, induced scattering of PECs associated with internalization of Endo180 into endosomes, loss of E-cadherin (CDH1/ECAD), and unzipping of cell-cell junctions. These findings are the first to demonstrate that a CTLD acts as a suppressor and regulatory switch for EMT; thus, positing that stabilization of Endo180-CD147 complex is a viable therapeutic strategy to improve rates of prostate cancer survival